washington | Regenerative Medicine Foundation

FDA, Patients, and Providers: A Brand New “Relation-shift.”

by Joseph Dawson | Aug 3, 2017 | News & Opinions

By Doug Oliver: I’m very positive about the future role of FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients AND therapy providers to be intentional in helping to...

FDA, Patients, and Providers: A Brand New “Relation-shift.”

Recent Posts

Pin It on Pinterest